143 related articles for article (PubMed ID: 30800218)
1. Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells.
Dosch AR; Dai X; Gaidarski Iii AA; Shi C; Castellanos JA; VanSaun MN; Merchant NB; Nagathihalli NS
Oncotarget; 2019 Feb; 10(10):1056-1069. PubMed ID: 30800218
[TBL] [Abstract][Full Text] [Related]
2. Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.
Galván JA; Zlobec I; Wartenberg M; Lugli A; Gloor B; Perren A; Karamitopoulou E
Br J Cancer; 2015 Jun; 112(12):1944-50. PubMed ID: 25989272
[TBL] [Abstract][Full Text] [Related]
3. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
4. Src-mediated regulation of E-cadherin and EMT in pancreatic cancer.
Nagathihalli NS; Merchant NB
Front Biosci (Landmark Ed); 2012 Jun; 17(6):2059-69. PubMed ID: 22652764
[TBL] [Abstract][Full Text] [Related]
5. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
[TBL] [Abstract][Full Text] [Related]
6. A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition.
Gasior K; Hauck M; Wilson A; Bhattacharya S
Theor Biol Med Model; 2017 Oct; 14(1):19. PubMed ID: 28992816
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor LEF-1 induces an epithelial-mesenchymal transition in MDCK cells independent of β-catenin.
Kobayashi W; Ozawa M
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):133-8. PubMed ID: 24269234
[TBL] [Abstract][Full Text] [Related]
8. TGF-β Signal Transduction in Pancreatic Carcinoma Cells is Sensitive to Inhibition by the Src Tyrosine Kinase Inhibitor AZM475271.
Bartscht T; Rosien B; Rades D; Kaufmann R; Biersack H; Lehnert H; Ungefroren H
Anticancer Agents Med Chem; 2017; 17(7):966-972. PubMed ID: 27671303
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-β, and E-cadherin in ameloblastoma.
Kurioka K; Wato M; Iseki T; Tanaka A; Morita S
Med Mol Morphol; 2017 Jun; 50(2):68-75. PubMed ID: 27995335
[TBL] [Abstract][Full Text] [Related]
10. Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer.
Kumar K; Chow CR; Ebine K; Arslan AD; Kwok B; Bentrem DJ; Eckerdt FD; Platanias LC; Munshi HG
Mol Cancer Res; 2016 Feb; 14(2):216-27. PubMed ID: 26609108
[TBL] [Abstract][Full Text] [Related]
11. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line.
Chen X; Liu X; Lang H; Zhang S; Luo Y; Zhang J
PLoS One; 2015; 10(3):e0121319. PubMed ID: 25799022
[TBL] [Abstract][Full Text] [Related]
12. Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action.
Bartscht T; Rosien B; Rades D; Kaufmann R; Biersack H; Lehnert H; Gieseler F; Ungefroren H
Mol Cancer; 2015 Nov; 14():199. PubMed ID: 26588899
[TBL] [Abstract][Full Text] [Related]
13. Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells.
Geismann C; Arlt A; Bauer I; Pfeifer M; Schirmer U; Altevogt P; Müerköster SS; Schäfer H
Int J Oncol; 2011 Jan; 38(1):257-66. PubMed ID: 21109948
[TBL] [Abstract][Full Text] [Related]
14. Activation of Focal Adhesion Kinase and Src Mediates Acquired Sorafenib Resistance in A549 Human Lung Adenocarcinoma Xenografts.
Zhou Q; Guo X; Choksi R
J Pharmacol Exp Ther; 2017 Dec; 363(3):428-443. PubMed ID: 29021381
[TBL] [Abstract][Full Text] [Related]
15. SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo.
Nishioka R; Itoh S; Gui T; Gai Z; Oikawa K; Kawai M; Tani M; Yamaue H; Muragaki Y
Exp Mol Pathol; 2010 Oct; 89(2):149-57. PubMed ID: 20576520
[TBL] [Abstract][Full Text] [Related]
16. TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways.
Baquero P; Jiménez-Mora E; Santos A; Lasa M; Chiloeches A
Mol Carcinog; 2016 Nov; 55(11):1639-1654. PubMed ID: 26392228
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
18. Posttranslational modification of E-cadherin by core fucosylation regulates Src activation and induces epithelial-mesenchymal transition-like process in lung cancer cells.
Shao K; Chen ZY; Gautam S; Deng NH; Zhou Y; Wu XZ
Glycobiology; 2016 Feb; 26(2):142-54. PubMed ID: 26443198
[TBL] [Abstract][Full Text] [Related]
19. Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.
Cao YW; Wan GX; Sun JP; Cui XB; Hu JM; Liang WH; Zheng YQ; Li WQ; Li F
Kaohsiung J Med Sci; 2015 Feb; 31(2):70-6. PubMed ID: 25645984
[TBL] [Abstract][Full Text] [Related]
20. CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Li K; Xu B; Xu G; Liu R
Tumour Biol; 2016 Jan; 37(1):419-24. PubMed ID: 26219899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
